EPISODE · Apr 10, 2023 · 15 MIN

Diet ESG

from Sustainability Now · host MSCI ESG Research LLC

This week we discuss the new anti-obesity drugs that many have claimed could spell an end to the world’s obesity epidemic. But ESG and diseases are not so straight forward. For example, we include diabetes medication but not obesity medication in our access to healthcare key issue. Why is that? We explore the topic in this week’s episode.Host: Mike Disabato, MSCI ESG ResearchGuest: Namita Nair, MSCI ESG Research

Episode metadata supplied by the publisher feed · Published Apr 10, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Diet ESG

0:00 15:31

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Sustainability Now?

This episode is 15 minutes long.

When was this Sustainability Now episode published?

This episode was published on April 10, 2023.

Can I download this Sustainability Now episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!